WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its nAAVigation™ Vector Platform (nAAVigation). Leveraging decades of ...

2024--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV ...

With the addition of Vigene, the Charles River cell and gene therapy portfolio will expand each major CDMO platform: cell therapy, viral vector, and plasmid DNA production, said CEO James Foster.

RADIUM SPRINGS, New Mexico -- Vector Control technicians are working to maintain the number of hatching mosquitos as the area north of Radium Springs has become overflowed with river water.

--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector ...

The move will expand Charles River's viral vector and plasmid DNA manufacturing repertoire—boosting its presence in a CDMO market valued at $2.5 billion globally and growing, the company said.

PITTSBURGH—Vector Security moved into the Hudson Valley area of New York for the first time with the acquisition, announced Feb. 8, of Poughkeepsie, N.Y.-based Hammond Security. “We like the employees ...

The US Army experimented with an autonomous boat to support wet gap crossing operations during the Maneuver Support & ...

Charles River also recently acquired a site in Rockville, Maryland, through its $350-million buyout of gene therapy CDMO Vigene Biosciences back in 2021. The site largely helps with the production ...